Mind the Decimal Point: A Case of Diazoxide Overdose-Induced Ileus
- PMID: 38989349
- PMCID: PMC11235150
- DOI: 10.7759/cureus.62088
Mind the Decimal Point: A Case of Diazoxide Overdose-Induced Ileus
Abstract
Diazoxide is the only medication approved by the United States Food and Drug Administration for the treatment of hyperinsulinism-induced hypoglycemia. Overdose is infrequently reported. This case describes a preterm four-week-old male who was prescribed diazoxide and chlorothiazide for perinatal stress-induced hyperinsulinism. The patient presented to the emergency department with feeding intolerance and abdominal distension following an accidental 10-fold diazoxide overdose. On presentation, vital signs were remarkable for tachycardia and intermittent tachypnea. Physical exam revealed a grossly distended abdomen. Laboratory abnormalities included a glucose of 216 mg/dL, sodium of 132 mmol/L, and chloride of 98 mmol/L. Abdominal X-ray interpretation found moderate gaseous distension suggestive of generalized ileus. The patient was admitted to the neonatal intensive care unit (NICU), and a nasogastric tube was placed. He received intravenous dextrose fluids, and enteral feeds were resumed as serial X-rays showed interval improvement. The patient remained in the NICU for several days to monitor bowel movements and resolution of ileus and he was discharged after improvement. While diazoxide overdose is rarely reported, and ileus due to such is documented even less frequently, 10-fold medication dose errors are common among infants. The source of the 10-fold mistake is often decimal points, leading zeros, or trailing zeros. Utilizing the smallest possible syringe for the prescribed dose may reduce the incidence of medication errors.
Keywords: diazoxide; hyperinsulinism; ileus; overdose; preterm infant; tenfold dosing error.
Copyright © 2024, Meleis et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- Hyperinsulinemic hypoglycemia. Güemes M, Hussain K. Pediatr Clin North Am. 2015;62:1017–1036. - PubMed
-
- Hyperinsulinism. Long D, Akhtar Y. Pediatr Rev. 2019;40:207–210. - PubMed
-
- Management and appropriate use of diazoxide in infants and children with hyperinsulinism. Brar PC, Heksch R, Cossen K, et al. J Clin Endocrinol Metab. 2020;105:543. - PubMed
Publication types
LinkOut - more resources
Full Text Sources